| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 47,084 | 49,152 | 54,562 | 73,242 | | Cost of Revenue | 37,247 | 43,010 | 54,471 | 96,890 | | | Gross Profit | 9,837 | 6,142 | 91 | (23,648) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,193 | 7,100 | 7,143 | 5,737 | | Non Recurring |
-
| 1,351 |
-
| 17,460 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,644 | (2,309) | (7,052) | (46,845) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21 | (97) | 21 | 33 | | Earnings Before Interest And Taxes | 4,617 | (2,327) | (7,076) | (46,830) | | Interest Expense | 789 | 671 | 705 | 797 | | Income Before Tax | 3,828 | (2,998) | (7,781) | (47,627) | | Income Tax Expense | 90 | (82) | (1,533) | (4,911) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,690 | (2,916) | (6,248) | (42,716) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,738 | (2,916) | (6,248) | (42,716) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,738 | ($2,916) | ($6,248) | ($42,716) |
|
0.03% Nasdaq 
0.22 (2.85%) 
Income Statement
